Literature DB >> 3831232

Influence of cysteine deprivation on chlamydial differentiation from reproductive to infective life-cycle forms.

I Allan, T P Hatch, J H Pearce.   

Abstract

The effects of omission of individual amino acids from growth medium on the differentiation of Chlamydia trachomatis DK-20 (serotype E) during infection of cycloheximide-treated McCoy cells are described. As judged by inclusion body staining with acridine orange, omission of cysteine from the medium severely retarded differentiation of reproductive reticulate body (RB) to infective elementary body (EB) forms. The effect appeared specific to cysteine in that omission of other amino acids had little or no effect on differentiation once RBs appeared. On restoration of cysteine, culture infectivity increased and inclusions contained organisms which, by cytochemical and morphological criteria, were differentiating to infective forms, indicating that cysteine deprivation did not irreversibly inhibit differentiation. Impairment of RB to EB differentiation in cysteine-less medium was also observed for three strains of Chlamydia psittaci and 10 other strains of C. trachomatis. It is suggested that the effect arises via the biosynthetic requirement for cysteine for provision of three cysteine-rich proteins, whose synthesis and insertion into the outer membrane have previously been shown to accompany RB to EB differentiation of C. psittaci 6BC and C. trachomatis 434 (serotype L2). Synthesis of cysteine-rich outer membrane proteins during differentiation may thus be common to all chlamydiae.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3831232     DOI: 10.1099/00221287-131-12-3171

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  11 in total

1.  Interaction of Chlamydia trachomatis serovar L2 with the host autophagic pathway.

Authors:  Hesham M Al-Younes; Volker Brinkmann; Thomas F Meyer
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

Review 2.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

3.  The nucleotide sequence of the 60 kDa cysteine rich outer membrane protein of Chlamydia psittaci strain EAE/A22/M.

Authors:  M W Watson; P R Lambden; I N Clarke
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

4.  Developmental stage-specific metabolic and transcriptional activity of Chlamydia trachomatis in an axenic medium.

Authors:  Anders Omsland; Janet Sager; Vinod Nair; Daniel E Sturdevant; Ted Hackstadt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-05       Impact factor: 11.205

5.  Reversion of the antichlamydial effect of tumor necrosis factor by tryptophan and antibodies to beta interferon.

Authors:  Y Shemer-Avni; D Wallach; I Sarov
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

6.  Chlamydial development is adversely affected by minor changes in amino acid supply, blood plasma amino acid levels, and glucose deprivation.

Authors:  A Harper; C I Pogson; M L Jones; J H Pearce
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

7.  Characterization of Pgp3, a Chlamydia trachomatis plasmid-encoded immunodominant antigen.

Authors:  Ding Chen; Lei Lei; Chunxue Lu; Ahmad Galaleldeen; P John Hart; Guangming Zhong
Journal:  J Bacteriol       Date:  2010-09-17       Impact factor: 3.490

8.  Altered developmental expression of polymorphic membrane proteins in penicillin-stressed Chlamydia trachomatis.

Authors:  Jose A Carrasco; Chun Tan; Roger G Rank; Ru-ching Hsia; Patrik M Bavoil
Journal:  Cell Microbiol       Date:  2011-04-26       Impact factor: 3.715

Review 9.  Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis.

Authors:  W L Beatty; R P Morrison; G I Byrne
Journal:  Microbiol Rev       Date:  1994-12

10.  Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence.

Authors:  W L Beatty; T A Belanger; A A Desai; R P Morrison; G I Byrne
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.